Gene · 54880
Papers3,332
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,141 to 1,160 of 3,332
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Case Report: Prenatal Diagnosis of a Novel Variant c.251dupT (p.N87Kfs*6) in BCOR Resulting in Oculofaciocardiodental Syndrome Using Whole-Exome Sequencing. | Front Genet | 2022 | 35401667 | PubTator, text mining | PubMed |
| Mature plasmacytoid dendritic cells associated with acute myeloid leukemia show similar genetic mutations and expression profiles to leukemia cells. | Blood Sci | 2022 | 35399539 | PubTator, text mining | PubMed |
| Importance of Early Next-Generation Sequencing in Microsatellite Unstable Colon Cancer With a High Tumor Mutation Burden. | Cureus | 2022 | 35399448 | PubTator, text mining | PubMed |
| Comprehensive analysis of genetic factors predicting overall survival in Myelodysplastic syndromes. | Sci Rep | 2022 | 35396491 | PubTator, text mining | PubMed |
| A proteolysis-targeting chimera molecule selectively degrades ENL and inhibits malignant gene expression and tumor growth. | J Hematol Oncol | 2022 | 35395864 | PubTator, text mining | PubMed |
| Nonsyndromic Generalized Radiculomegaly of Permanent Dentition: A Rare Case Report. | Case Rep Dent | 2022 | 35392487 | PubTator, text mining | PubMed |
| Low-Risk Myelodysplastic Syndrome Revisited: Morphological, Autoimmune, and Molecular Features as Predictors of Outcome in a Single Center Experience. | Front Oncol | 2022 | 35392224 | PubTator, text mining | PubMed |
| Evaluation of Tumor DNA Sequencing Results in Patients with Gastric and Gastroesophageal Junction Adenocarcinoma Stratified by TP53 Mutation Status. | Oncologist | 2022 | 35380714 | PubTator, text mining | PubMed |
| Bayesian networks elucidate complex genomic landscapes in cancer. | Commun Biol | 2022 | 35379892 | PubTator, text mining | PubMed |
| Concordance of Peripheral Blood and Bone Marrow Next-Generation Sequencing in Hematologic Neoplasms. | Adv Hematol | 2022 | 35378848 | PubTator, text mining | PubMed |
| Clinical relevance of serum-derived exosomal messenger RNA sequencing in patients with non-Hodgkin lymphoma. | J Cancer | 2022 | 35371331 | PubTator, text mining | PubMed |
| Genomic landscape of endometrial carcinomas of no specific molecular profile. | Mod Pathol | 2022 | 35365770 | PubTator, text mining | PubMed |
| [Endometrial and other rare uterine sarcomas : Diagnostic aspects in the context of the 2020 WHO classification]. | Pathologe | 2022 | 35362728 | PubTator, text mining | PubMed |
| A New BCl6 Transcriptional Corepressor Variant Mosaicism in a Fetus with Severe Fetal-Eye Anomalies. | Fetal Diagn Ther | 2022 | 35358978 | PubTator, text mining | PubMed |
| X Chromosome Inactivation Timing is Not eXACT: Implications for Autism Spectrum Disorders. | Front Genet | 2022 | 35356429 | PubTator, text mining | PubMed |
Morphologic, immunophenotypic, and molecular genetic comparison study in patients with clonal cytopenia of undetermined significance, myelodysplastic syndrome, and acute myeloid leukemia with myelodysplasia-related changes: A single institution experience. | Int J Lab Hematol | 2022 | 35352484 | PubTator, text mining | PubMed |
| Rapid and highly sensitive approach for multiplexed somatic fusion detection. | Mod Pathol | 2022 | 35347250 | PubTator, text mining | PubMed |
| A retrospective comparison of salvage intensive chemotherapy versus venetoclax-combined regimen in patients with relapsed/refractory acute myeloid leukemia (AML). | Ther Adv Hematol | 2022 | 35340720 | PubTator, text mining | PubMed |
| Genetic heterogeneity and therapeutic target detection through microdissection in solid-type adenoid cystic carcinoma. | Pathology | 2022 | 35337667 | PubTator, text mining | PubMed |
| Role of Pharmacogenetics in the Treatment of Acute Myeloid Leukemia: Systematic Review and Future Perspectives. | Pharmaceutics | 2022 | 35335935 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54880/papers?page=58